MedPath

COVID-19 and Children with congenital heart disease

Not Applicable
Conditions
Health Condition 1: Q20- Congenital malformations of cardiac chambers and connectionsHealth Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2020/10/028251
Lead Sponsor
Pediatric Cardiac Society of India
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

a)All Paediatric patients ( <18 years of age) with heart disease

b)All grown-up adults with congenital heart disease (operated or unoperated)

c)Admitted to the participating hospitals in the study period

d)And tested positive for COVID-19 with any of the available tests in the preceding 28 days

Exclusion Criteria

Complete medical records not retrievable

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To study the outcome of children hospitalized with heart disease and COVID-19 infection between 01 April 2020 and 31 Aug 2020Timepoint: Outcome data will be collected retrospectively, till the time of death/recovery/discharge from hospital
Secondary Outcome Measures
NameTimeMethod
1.To find out the monthly congenital heart disease (CHD) admissions during the same period in different parts of India and to assess the impact of various phases of lockdown and its relaxations on admission rates. <br/ ><br> <br/ ><br>2.To find out overall congenital heart disease related mortality (COVID as well as Non-COVID) rate among patients admitted to the various hospitals in India during the COVID 19 pandemic as compared to the corresponding period in 2019.Timepoint: Outcome data will be collected retrospectively at the end of study period, that is 30 Aug 2020
© Copyright 2025. All Rights Reserved by MedPath